Portage Biotech Inc

PRTG

Company Profile

  • Business description

    Portage Biotech Inc is engaged in researching and developing pharmaceutical and biotech products through clinical proof of concept with an initial focus on unmet clinical needs. It is an immune-oncology company focused on overcoming immune resistance and currently managing 10 immuno-oncology assets at various development stages. Its pipeline products include IMM-60; IMM60 + Cell Therapy; (IMM60 / NY-ESO-1) + Keytruda and others.

  • Contact

    Clarence Thomas Building
    P.O. Box 4649
    Tortola
    Road TownVG1110
    VGB

    T: +1 203 221-7378

    https://www.portagebiotech.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 March 2026

    Employees

    7

Stocks News & Analysis

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,369.304.70-0.06%
CAC 407,690.2637.67-0.49%
DAX 4023,160.61183.93-0.79%
Dow JONES (US)40,877.89340.94-0.83%
FTSE 1008,585.9410.41-0.12%
HKSE22,662.71158.030.70%
NASDAQ17,631.26212.98-1.19%
Nikkei 22536,830.69378.391.04%
NZX 50 Index12,421.090.16-0.00%
S&P 5005,597.6452.74-0.93%
S&P/ASX 2008,151.406.40-0.08%
SSE Composite Index3,316.1137.081.13%

Market Movers